Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice.

Flavonoids have been identified as the antidiabetic components in a number of traditional ethnic remedies. However, the mechanisms whereby these compounds exert their hypoglycemic and hypolipidemic action in type-2 diabetes have rarely been investigated. Therefore, this study investigated the effect of the flavonoids hesperidin and naringin on glucose and lipid regulation in C57BL/KsJ-db/db mice. Hesperidin and naringin both significantly increased the glucokinase mRNA level, while naringin also lowered the mRNA expression of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in the liver. In addition, the hepatic glucose transporter 2 protein expression was significantly reduced, while the expression of adipocyte glucose transporter 4 and hepatic and adipocyte peroxisome proliferator-activated receptor gamma were elevated in the hesperidin and naringin groups when compared with the control group. Furthermore, hesperidin and naringin effectively lowered the plasma free fatty acid and plasma and hepatic triglyceride levels, and simultaneously reduced the hepatic fatty acid oxidation and carnitine palmitoyl transferase activity. These changes were seemingly attributable to a suppression of the hepatic fatty acid synthase, glucose-6-phosphate dehydrogenase, and phosphatidate phosphohydrolase activities and an increase in the fecal triglycerides. The two flavonoids also led to a decrease in the plasma and hepatic cholesterol levels that may have been partly due to the decreased hepatic 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase and acyl CoA: cholesterol acyltransferase (ACAT) activities and increased fecal cholesterol. Consequently, the current results suggest that hesperidin and naringin are beneficial for improving hyperlipidemia and hyperglycemia in type-2 diabetic animals by partly regulating the fatty acid and cholesterol metabolism and affecting the gene expression of glucose-regulating enzymes.

[1]  K P Hummel,et al.  Diabetes, a New Mutafton in the Mouse , 1966, Science.

[2]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[3]  G. Jarvik,et al.  Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. , 2003, Annual review of medicine.

[4]  J. Kuhnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976 .

[5]  R. Schimke,et al.  Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. , 1974, Biochimica et biophysica acta.

[6]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[7]  J. McGarry,et al.  Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.

[8]  N. Borradaile,et al.  Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation. , 2003, Diabetes.

[9]  J. Porter,et al.  Fatty-acid synthase from rat liver. , 1975, Methods in enzymology.

[10]  J. Girard,et al.  Troglitazone Inhibits Fatty Acid Oxidation and Esterification, and Gluconeogenesis in Isolated Hepatocytes from Starved Rats , 1996, Diabetes.

[11]  M. Blay,et al.  Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. , 2004, Endocrinology.

[12]  G. Shulman,et al.  Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver , 2001, Nature.

[13]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[14]  Y. Terauchi,et al.  The Mechanisms by Which Both Heterozygous Peroxisome Proliferator-activated Receptor γ (PPARγ) Deficiency and PPARγ Agonist Improve Insulin Resistance* , 2001, The Journal of Biological Chemistry.

[15]  J. Pessin,et al.  Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). , 1995, The Journal of clinical investigation.

[16]  C. Hofmann,et al.  Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. , 1993, The American journal of physiology.

[17]  J. Lee,et al.  Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. , 2003, Clinical nutrition.

[18]  B. Jena,et al.  Impaired Hepatocyte Glucose Transport Protein (GLUT2) Internalization in Chronic Pancreatitis , 2001, Pancreas.

[19]  G. Waeber,et al.  Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver. , 1996, The Biochemical journal.

[20]  Yun-ping Zhou,et al.  A Fatty Acid—Induced Decrease in Pyruvate Dehydrogenase Activity Is an Important Determinant of β-Cell Dysfunction in the Obese Diabetic db/db Mouse , 1996, Diabetes.

[21]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[22]  Y. Ahn,et al.  Liver glucokinase can be activated by peroxisome proliferator-activated receptor-gamma. , 2004, Diabetes.

[23]  A. Shisheva,et al.  Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. , 1992, Biochemistry.

[24]  Young‐Bae Park,et al.  Naringin Has an Antiatherogenic Effect With the Inhibition of Intercellular Adhesion Molecule-1 in Hypercholesterolemic Rabbits , 2001, Journal of cardiovascular pharmacology.

[25]  D. Stein,et al.  Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes. , 2003, Diabetes.

[26]  A. L. Kerbey,et al.  Mechanisms decreasing glucose oxidation in diabetes and starvation: role of lipid fuels and hormones. , 1988, Diabetes/metabolism reviews.

[27]  D. Meyer,et al.  Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. , 1980, Journal of lipid research.

[28]  K. Jeong,et al.  The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. , 2004, The Journal of nutrition.

[29]  J. Friedman,et al.  Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription and Hyperglycemia Are Regulated by Glucocorticoids in Genetically Obesedb/db Transgenic Mice* , 1997, The Journal of Biological Chemistry.

[30]  R. Burcelin,et al.  Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. , 1992, The Biochemical journal.

[31]  O. Pitkänen,et al.  Enzymatic Determination of Unbound D-Mannose in Serum , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[32]  D. M. Rocha,et al.  Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. , 1999, Diabetes.

[33]  T. Asano,et al.  Increased Liver Glucose-Transporter Protein and mRNA in Streptozocin-Induced Diabetic Rats , 1990, Diabetes.

[34]  E. Shafrir,et al.  Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage , 2005, Diabetes/metabolism research and reviews.

[35]  M. Aviram,et al.  Preservation of Paraoxonase Activity by Wine Flavonoids , 2002 .

[36]  O. Kwon,et al.  Flavonoid Inhibition of Sodium-dependent Vitamin C Transporter 1 (SVCT1) and Glucose Transporter Isoform 2 (GLUT2), Intestinal Transporters for Vitamin C and Glucose* , 2002, The Journal of Biological Chemistry.

[37]  K. Nair,et al.  Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. , 2003, Diabetes.

[38]  P. Durrington,et al.  The hunt for nutritional and pharmacological modulators of paraoxonase. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[39]  D. Granner,et al.  Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production* , 2002, The Journal of Biological Chemistry.

[40]  N. Tolbert,et al.  The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. , 1973, The Journal of biological chemistry.

[41]  P. Winocour,et al.  Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. , 1991, Atherosclerosis.

[42]  J. Foley,et al.  Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus , 1992, Diabetes Care.

[43]  I. Fritz.  Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. , 1961, Physiological reviews.

[44]  J. Reddy,et al.  PAT5A: A Partial Agonist of Peroxisome Proliferator-Activated Receptor γ Is a Potent Antidiabetic Thiazolidinedione Yet Weakly Adipogenic , 2003, Journal of Pharmacology and Experimental Therapeutics.

[45]  K. Suckling,et al.  Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. , 1985, Journal of lipid research.

[46]  A. Kahn,et al.  Transcriptional regulation by glucose in the liver. , 1997, Biochimie.

[47]  M. Velasquez,et al.  Beneficial role of dietary phytoestrogens in obesity and diabetes. , 2002, The American journal of clinical nutrition.

[48]  Jen-kun Lin,et al.  Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator‐activated receptor‐γ by flavonoids in mouse macrophages , 2001, FEBS letters.

[49]  I. Yamaguchi,et al.  Development of hyperglycaemia and insulin resistance in conscious genetically diabetic (C57BL/KsJ-db/db) mice , 1994, Diabetologia.

[50]  P. Iynedjian,et al.  Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. , 1988, The Journal of biological chemistry.

[51]  F. Hulcher,et al.  Simplified Spectrophotometric Assay for Microsomal 3-hydroxy-3-methylglutaryl Coa Reductase by Measurement of Coenzyme A , 2022 .

[52]  M. Muñoz,et al.  Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. , 2001, Diabetes.

[53]  G. Shulman,et al.  Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.

[54]  P. Walton,et al.  The role of Mg2+-dependent phosphatidate phosphohydrolase in pulmonary glycerolipid biosynthesis. , 1984, Biochimica et biophysica acta.

[55]  K. Feingold,et al.  Fatty Acid Synthesis in Obese Insulin Resistant Diabetic Mice , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[56]  H. Horikoshi,et al.  Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits. , 1999, Atherosclerosis.

[57]  F. Bosch,et al.  Correction of diabetic alterations by glucokinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. McGarry.  Disordered metabolism in diabetes: Have we underemphasized the fat component? , 1994, Journal of cellular biochemistry.

[59]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[60]  T. Yokozawa,et al.  Improvement of hyperglycemia and hyperlipemia in streptozotocin-diabetic rats by a methanolic extract of Prunus davidiana stems and its main component, prunin. , 1991, Planta medica.

[61]  E. Harrison,et al.  Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis in rat liver. , 1991, The Journal of nutrition.

[62]  Fang Liu,et al.  Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. , 2005, The Journal of nutrition.

[63]  P. Kris-Etherton,et al.  Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health , 2002, Current opinion in lipidology.

[64]  S. Brichard,et al.  Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism , 1993, Diabetologia.

[65]  N. Cherry,et al.  Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. , 2003, Pharmacogenetics.

[66]  P. Lazarow.  Assay of peroxisomal beta-oxidation of fatty acids. , 1981, Methods in enzymology.

[67]  H. G. Windmueller,et al.  De novo synthesis of fatty acid in perfused rat liver as a determinant of plasma lipoprotein production. , 1967, Archives of biochemistry and biophysics.

[68]  T. Anno,et al.  Effect of hesperetin, a citrus flavonoid, on the liver triacylglycerol content and phosphatidate phosphohydrolase activity in orotic acid-fed rats , 2001, Plant foods for human nutrition.

[69]  M. Brown,et al.  The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. , 1980, The Journal of biological chemistry.

[70]  A. Aro,et al.  Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. , 2001, The Journal of nutrition.